COMPARATIVE-STUDY OF AZITHROMYCIN AND AMOXICILLIN CLAVULANIC ACID IN THE TREATMENT OF LOWER RESPIRATORY-TRACT INFECTIONS

被引:38
作者
BALMES, P
CLERC, G
DUPONT, B
LABRAM, C
PARIENTE, R
POIRIER, R
机构
[1] CTR HOSP SPECIALISE, F-50170 PONTORSON, FRANCE
[2] HOP LOUIS PASTEUR, SERV MALAD INFECT, F-75015 PARIS, FRANCE
[3] CTR HOSP CHALONS SUR MARNE, SERV MED INTERNE, F-51005 CHALONS SUR MARNE, FRANCE
[4] HOP BEAUJON, SERV PNEUMOL & REANIMAT, F-92110 CLICHY, FRANCE
[5] CTR HOSP AIX EN PROVENCE, SERV PNEUMOL, F-13616 AIX EN PROVENCE, FRANCE
关键词
D O I
10.1007/BF01968024
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Forty-eight patients with acute bronchitis and four with pneumonia were randomly assigned to receive five doses (500 mg on day 1, plus 250 mg/day on days 2-5) of azithromycin; 54 patients with acute bronchitis and four with pneumonia were assigned 30 doses (625 mg every eight hours for ten days) of amoxicillin/clavulanic acid (CA). The two regimens were equally effective, with clinical improvement or cure in 92% and 87% of patients respectively, bacteriological cure in 89% and 86%, with 91% and 89% of pathogens eliminated. Minor side effects occurred in 6% and 12% of patients in the two groups, respectively. No major abnormalities in laboratory, safety parameters were seen in either group.
引用
收藏
页码:437 / 439
页数:3
相关论文
共 4 条
[1]   SYNTHESIS, INVITRO AND INVIVO ACTIVITY OF NOVEL 9-DEOXO-9A-AZA-9A-HOMOERYTHROMYCIN A DERIVATIVES - A NEW CLASS OF MACROLIDE ANTIBIOTICS, THE AZALIDES [J].
BRIGHT, GM ;
NAGEL, AA ;
BORDNER, J ;
DESAI, KA ;
DIBRINO, JN ;
NOWAKOWSKA, J ;
VINCENT, L ;
WATROUS, RM ;
SCIAVOLINO, FC ;
ENGLISH, AR ;
RETSEMA, JA ;
ANDERSON, MR ;
BRENNAN, LA ;
BOROVOY, RJ ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
GIRARD, AE ;
GIRARD, D ;
HERBERT, C ;
MANOUSOS, M ;
MASON, R .
JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1029-1047
[2]   THE PHARMACOKINETICS OF AZITHROMYCIN IN HUMAN SERUM AND TISSUES [J].
FOULDS, G ;
SHEPARD, RM ;
JOHNSON, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :73-82
[3]   PHARMACOKINETIC AND INVIVO STUDIES WITH AZITHROMYCIN (CP-62,993), A NEW MACROLIDE WITH AN EXTENDED HALF-LIFE AND EXCELLENT TISSUE DISTRIBUTION [J].
GIRARD, AE ;
GIRARD, D ;
ENGLISH, AR ;
GOOTZ, TD ;
CIMOCHOWSKI, CR ;
FAIELLA, JA ;
HASKELL, SL ;
RETSEMA, JA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1948-1954
[4]   SPECTRUM AND MODE OF ACTION OF AZITHROMYCIN (CP-62,993), A NEW 15-MEMBERED-RING MACROLIDE WITH IMPROVED POTENCY AGAINST GRAM-NEGATIVE ORGANISMS [J].
RETSEMA, J ;
GIRARD, A ;
SCHELKLY, W ;
MANOUSOS, M ;
ANDERSON, M ;
BRIGHT, G ;
BOROVOY, R ;
BRENNAN, L ;
MASON, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1939-1947